Morgan Stanley Maintains Ametek (AME) Overweight Recommendation

AMETEK, Inc.
US ˙ NYSE ˙ US0311001004

Morgan Stanley Maintains Ametek (AME) Overweight Recommendation

Morgan Stanley Maintains Ametek (AME) Overweight Recommendation
2023-08-02 15:16
US

Fintel reports that on August 2, 2023, Morgan Stanley maintained coverage of Ametek (NYSE:AME) with a Overweight recommendation.

Analyst Price Forecast Suggests 5.54% Upside

As of August 1, 2023, the average one-year price target for Ametek is 167.39. The forecasts range from a low of 156.55 to a high of $189.00. The average price target represents an increase of 5.54% from its latest reported closing price of 158.60.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Ametek is 6,494MM, an increase of 1.14%. The projected annual non-GAAP EPS is 6.03.

What is the Fund Sentiment?

There are 1687 funds or institutions reporting positions in Ametek. This is an increase of 53 owner(s) or 3.24% in the last quarter. Average portfolio weight of all funds dedicated to AME is 0.39%, a decrease of 3.64%. Total shares owned by institutions decreased in the last three months by 4.06% to 239,233K shares. AME / Ametek Inc Put/Call Ratios The put/call ratio of AME is 0.48, indicating a bullish outlook.

What are Other Shareholders Doing?

AME / Ametek Inc Shares Held by Institutions

Massachusetts Financial Services holds 8,571K shares representing 3.72% ownership of the company. In it's prior filing, the firm reported owning 8,505K shares, representing an increase of 0.77%. The firm decreased its portfolio allocation in AME by 84.24% over the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 7,125K shares representing 3.09% ownership of the company. In it's prior filing, the firm reported owning 6,982K shares, representing an increase of 2.01%. The firm decreased its portfolio allocation in AME by 1.98% over the last quarter.

Price T Rowe Associates holds 6,394K shares representing 2.77% ownership of the company. In it's prior filing, the firm reported owning 3,953K shares, representing an increase of 38.17%. The firm increased its portfolio allocation in AME by 56.56% over the last quarter.

VIMSX - Vanguard Mid-Cap Index Fund Investor Shares holds 5,374K shares representing 2.33% ownership of the company. In it's prior filing, the firm reported owning 5,345K shares, representing an increase of 0.53%. The firm increased its portfolio allocation in AME by 1.23% over the last quarter.

VFINX - Vanguard 500 Index Fund Investor Shares holds 5,359K shares representing 2.33% ownership of the company. In it's prior filing, the firm reported owning 5,309K shares, representing an increase of 0.93%. The firm decreased its portfolio allocation in AME by 2.63% over the last quarter.

Ametek Background Information
(This description is provided by the company.)

AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with 2019 sales of approximately $5.0 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500.

Additional reading:

Other Listings
IT:1AME 154,00 €
MX:AME
GB:0HF7 188,44 US$
AT:AME
DE:AK1 159,22 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista